Skip to main content

Table 5 Antimicrobial resistance profile of diarrheagenic E. coli isolated from stool samples collected from children

From: Prevalence of multi drug resistant enteropathogenic and enteroinvasive Escherichia coli isolated from children with and without diarrhea in Northeast Indian population

DEC (n) AMP AK C CN CI CF COT CST MRP NX G CFM DO OF MDR (%)
a-EPEC (29) 21 (72.4) 06 (20.7) 14 (48.3) 14 (48.3) 22 (75.9) 10 (34.5) 09 (31.0) 24 (82.8) 06 (20.7) 12 (41.4) 04 (13.8) 21 (72.4) 12 (41.4) 14 (48.3) 14 (48.3)
t-EPEC (21) 14 (66.7) 08 (38.1) 05 (23.8) 12 (57.1) 12 (57.1) 03 (14.3) 08 (38.1) 16 (76.2) 06 (28.6) 09 (42.6) 07 (33.3) 12 (57.1) 12 (57.1) 07 (33.3) 07 (24.1)
EIEC (08) 07 (87.5) 01 (12.5) 00 (0) 06 (75) 07 (87.5) 04 (50) 07 (87.5) 04 (50) 05 (62.5) 01 (12.5) 05 (62.5) 05 (62.5) 05 (62.5) 05 (62.5) 03 (37.5)
Total (58) 42 (72.4) 15 (25.9) 19 (32.8) 32 (55.2) 41 (70.7) 17 (29.3) 24 (41.4) 44 (75.9) 17 (29.3) 22 (37.9) 16 (27.6) 38 (65.5) 29 (50) 26 (44.8) 24 (41.4)
  1. Figures in parenthesis denotes the % of the samples
  2. MDR multi drug resistant, a-EPEC atypical enteropathogenic Escherichia coli, t-EPEC typical enteropathogenic Escherichia coli, EIEC enteroinvasive Escherichia coli, μg microgram, Antibiotics ampicillin (AMP10 = 10 μg), amikacin (AK10 = 10 μg), chloramphenicol (C 30 = 30 μg), ceftriaxone (CI 10 = 10 μg), cephalexin (CN30 = 30 μg), ciprofloxacin (CF10 = 10 μg), co-trimoxazole (COT25 = trimethoprim 1.25 μg and sulphamethoxazole 23.75 μg), cefoperazone–tazobactam (CST 75–10 μg), meropenem (MRP10 = 10 μg), norfloxacin (NX10 = 10 μg), gentamicin (G10 = 10 μg), cefixime (CFM 5 = 5 μg), doxycycline hydrochloride (DO10 = 10 μg) and ofloxacin (OF 5 = 5 μg)